Rhythm Pharmaceuticals buy Guggenheim
Start price
06.08.25
/
50%
€77.50
Target price
06.08.26
€103.73
Performance (%)
-14.84%
Price
09:46
?
Summary
This prediction is currently active. The price of Rhythm Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.84%. This prediction currently runs until 06.08.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 0.000% | 0.000% |
| iShares Core DAX® | 1.604% | -7.448% |
| iShares Nasdaq 100 | -0.734% | -1.864% |
| iShares Nikkei 225® | 1.296% | -6.795% |
| iShares S&P 500 | -0.394% | -2.336% |
Comments by Guggenheim for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Guggenheim from $119.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Guggenheim for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€46.40
21.10.24
21.10.24
€64.45
21.10.25
21.10.25
95.04%
22.10.25
22.10.25
